AB0811 DIRECT COST OF BIOLOGICS IN RHEUMATOID ARTHRITIS PATIENTS IN A DEVELOPING COUNTRY: RESULTS FOR THE MOROCCAN RBSMR REGISTRY
2021
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI